News

EIT Community New European Bauhaus (NEB) 2025 Open Calls

Published on | 10 months ago

Programmes EIT

The EIT Community New European Bauhaus (NEB) invites applicants to submit proposals for funding through its community-focused Co-create and Connect NEB calls for proposals, which focuses on new solutions to boost the transformation of cities, rural and peri-urban areas.

The EIT Community NEB is especially interested in receiving applications for projects that address challenges related to climate, urban mobility, food and manufacturing.

For more information on the application process, please visit the dedicated pages below: 

>Connect New European Bauhaus Open Call 2025

>Co-create New European Bauhaus Open Call 2025

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1637 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.